Not only are the copy-cat manufacturers of cheaper generic drugs becoming emboldened by cost-conscious politicians and legal rulings in their favour, but big pharmaceutical companies are also facing an unprecedented wave of patent expirations over the next five years.
Flow signals were analysed to calculate the average number of incomplete expirations over a 20 breath window.
More broadly, given the slew of patent expirations over the next couple years, and a generic-friendly White House, drug companies like Watson look well-positioned for steady growth, analysts argue.
All measurements were made at end-expiration over five consecutive cardiac cycles.
Glaxo shares have fallen 8% this year over fears about patent expiration, litigation over antidepressant Paxil and price regulations.
Finally, the April 60 calls, which command a delta that indicates a 13% chance of landing in-the-money by expiration, had over 2,600 calls snagged by bulls who shelled out 63 cents for the contracts.
Expiration dates on over-the-counter cosmetics or skin care products, with the exception of sunscreen, which is classified as a drug, aren't mandated by the Food and Drug Administration.
Options expire but can be rolled over to new expiration dates by selling the existing option and purchasing a new one.
Already Merck, Bristol-Myers Squibb and Schering-Plough are feeling the pinch as patent expirations loom over their aging arsenal.
However, if the good is perished before reaching the customer (the expiration date is over), the cost would be added to other costs such as transportation, production, and maintenance costs in the target function.
